Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
Latest in Oncology/Hematology
Retrospective study answers questions raised in shift to screening at age 45
Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy
-- News, features, and commentary about cancer-related issues
In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy
-- News, features, and commentary about cancer-related issues
In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Likelihood of severe maternal morbidity more than 20 times higher versus the general population
Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease
Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone